20111 results for «»
20111 results
Rapid-Fire - Rare and unusual (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Immerse yourself in a captivating collection of rare and unusual interventional cardiology cases. Witness the first known case of dual valve-in-valve replacement in caval valve implantation, the management of device-related allergic reactions, and the treatment of left atrial thrombi associated with appendage occlusion devices. Explore solutions...
Rapid-fire - TAVI in aortic regurgitation
24 Nov 2024 – From PCR London Valves 2024
Prepare to be captivated by a rapid-fire session showcasing selected PCR London Valves 2024 clinical cases on TAVI in aortic regurgitation. Witness the first-in-man deployment of the Abbott Navitor Valve for left ventricular assist device-associated aortic regurgitation, as well as cases involving severe aortic regurgitation in...
Breaking new ground in mitral valve interventions
24 Nov 2024 – From PCR London Valves 2024
What’s shaping the future of mitral valve therapies? This video from PCR London Valves 2024 unveils groundbreaking late-breaking trials that redefine the possibilities in mitral interventions.
You'll explore real-world insights from the OCEAN-Mitral registry on the MitraClip G4, uncover the link between tricuspid regurgitation and 3-year mortality...
Advanced mitral TEER - LIVE case
Recommended by PCR
24 Nov 2024 – From PCR London Valves 2024
Join us for a LIVE case followed by a recorded case highlighting advanced treatments for severe secondary mitral regurgitation:
- A 75-year-old man with permanent AF, a history of CABG, and symptomatic severe secondary MR (atrial and ischemic causes) with low LV function (45%) underwent mitral repair with...
Rapid-fire - TAVI-in-TAVI (Part 1)
24 Nov 2024 – From PCR London Valves 2024
This rapid-fire session on TAVI-in-TAVI (Part 1) features selected clinical case submissions from PCR London Valves 2024. Gain insights into strategies for redo TAVI to treat paravalvular leak, valve-in-valve bailout techniques, the use of the Myval Octacor valve-in-valve approach, and other challenges and solutions in managing...
How to establish a mitral TEER programme
24 Nov 2024 – From PCR London Valves 2024
Ready to start your journey toward establishing a mitral TEER programme? This video covers everything you need to know—from understanding the contemporary role of TEER in managing mitral regurgitation to building a Heart Team and referral network.
Learn how to find your first cases, select the right...
Insights from the top late-breaking trials at PCR London Valves 2024
24 Nov 2024 – From PCR London Valves 2024
Looking to stay ahead in transcatheter valve therapies? Don't miss out this video showcasing the most impactful late-breaking trials from PCR London Valves 2024.
Discover pivotal findings, including one-year results comparing two balloon-expandable TAVI valves, outcomes of the TRISCEND II trial for tricuspid regurgitation and groundbreaking insights...
Rapid-fire - TAVI
24 Nov 2024 – From PCR London Valves 2024
Dive into this rapid-fire session showcasing selected PCR London Valves 2024 Clinical Cases submissions related to TAVI. Explore diverse and challenging TAVI scenarios, including TAVI in patients with cardiogenic shock, pure aortic regurgitation, and patient-prosthesis mismatch. Gain insights into troubleshooting techniques and strategies for navigating complex...
Jon Zubiaur
Madrid, Spain
María Beltrán
Madrid, Spain
Emiliano Bianchini
Rome, Italy
Javier Cuesta
Madrid, Spain
Future directions of drug-coated balloon angioplasty
06 Feb 2025
Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.
Author
Author
Ultrasound-guided versus fluoroscopy-guided large-bore femoral access in PCI of complex coronary lesions: the international, multicentre, randomised ULTRACOLOR Trial
02 Dec 2024
Compared to fluoroscopy guidance, routine use of ultrasound for large-bore transfemoral access in complex PCI did not significantly reduce clinically relevant bleeding or vascular complications. However, it notably improved first-pass puncture success, with a very low crossover rate.
Reviewer
Reviewer
Featured cases - TAVI coronary protection strategies (Part 3)
26 Nov 2024 – From PCR London Valves 2024
This session, part of the Featured Cases series from PCR London Valves 2024, focuses on TAVI coronary protection strategies. Explore various challenging cases, including valve-in-valve TAVI scenarios with the risk of left main artery obstruction, orthotopic chimney stenting following valve-in-valve TAVI, and the management of post-dilatation...
Featured cases - TAVI in bicuspid valve anatomy (Part 2)
26 Nov 2024 – From PCR London Valves 2024
This session, part of the Featured Cases series from PCR London Valves 2024, focuses on TAVI in bicuspid valve anatomy. Dive into various complex cases, including TAVI in bicuspid type 0 with severe calcification, tailored sizing strategies in bicuspid aortic valve, and the utility of novel...
What is EuroPCR?
Featured cases - TAVI nightmares (Part 4)
26 Nov 2024 – From PCR London Valves 2024
This session, part of the Featured Cases series from PCR London Valves 2024, delves into the management of TAVI nightmares. Explore a range of complex and unexpected complications, such as left ventricular pseudo-aneurysm, suicide left and right ventricle, contained aortic annular rupture, and type A aortic...
Let it heal!
05 Feb 2025
The purpose of this case report is to discuss the treatment of a chronic total occlusion (CTO) in a 58-year-old male patient with multiple cardiovascular risk factors including type 2 diabetes, dyslipidemia, hypertension, and smoking history.
Angio showed a CTO of the RCA. In the MR-Scan, the RCA...
Author
Failed thrombus aspiration and reduced myocardial perfusion in patients with STEMI and large thrombus burden
03 Dec 2024
This registry-based observational study demonstrated that, in patients with STEMI and LTB, TA failure was associated with reduced myocardial perfusion and increased all-cause and cardiovascular mortality.
Reviewer
Reviewer
